Genesis IBRC India Limited has received in-principle approval from BSE Limited for a preferential issue of equity shares worth ₹40.25 crore. The company announced this significant corporate development on March 13, 2026, marking a key milestone in its capital raising initiative.

BSE Approval Details

The approval was granted through BSE's letter reference number LOD/PREF/GB/FIP/1863/2025-26 dated March 12, 2026. The exchange has provided its consent for the company to proceed with the preferential issue under Regulation 28 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance Requirements

BSE has outlined comprehensive compliance requirements that Genesis IBRC must fulfill for the successful completion of this preferential issue. The company must ensure strict adherence to multiple regulatory frameworks including the Companies Act 2013, Securities Contracts (Regulation) Act 1956, SEBI Act 1992, and the Depositories Act 1996.

The exchange has specifically emphasized compliance with:

• Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
• SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Listing Agreement provisions signed with BSE

Internal Controls and Monitoring

BSE has advised Genesis IBRC to strengthen internal controls to monitor trades executed by proposed allottees in the company's scrip before allotment. The company must obtain undertakings from allottees confirming they will not engage in intra-day trading or sell company shares until the allotment date, as required under SEBI ICDR Regulations.

Key monitoring requirements include:

• Verification of allottee compliance with trading restrictions
• Ensuring adherence to Regulation 167(6) of SEBI ICDR Regulations 2018
• Understanding that non-compliance may impact share listing

Post-Issue Formalities and Timeline

Following the allotment of securities, Genesis IBRC must submit a listing application without delay, along with applicable fees, in accordance with Regulation 14 of the LODR Regulations. The company has been specifically notified that it must apply for listing within twenty days from the date of allotment, as per Schedule XIX – Para (2) of ICDR Regulations and SEBI circular dated June 21, 2023.

Non-compliance with the twenty-day timeline will attract penalties as specified in the relevant SEBI circular. BSE reserves the right to withdraw this in-principle approval if any submitted information is found to be incomplete, incorrect, misleading, or in contravention of applicable regulations.

Genesis IBRC India Limited has achieved another milestone in its corporate transformation journey by receiving in-principle approval from BSE Limited for its name change to CCME Global Limited. The approval, granted through letter reference number DSC/NC/AC/IP/053/2025-2026 dated March 11, 2026, follows the successful completion of the postal ballot process where shareholders unanimously approved all 11 resolutions including the name change proposal.

BSE In-Principle Approval Details

The exchange granted its approval subject to completion of all formalities and compliance with Regulation 45 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will be required to submit a formal name change application to BSE after receiving ROC approval, along with certified true copy of the shareholder resolution.

Postal Ballot Process and Results

The postal ballot was conducted through remote e-voting facility provided by Central Depository Services (India) Limited from February 4, 2026 at 9:00 a.m. to March 5, 2026 at 5:00 p.m. Mr. Piyush A. Gohel (Membership no. F9068, COP no.: 27451), Practicing Company Secretary from Mumbai, served as the scrutinizer for the entire process.

Corporate Transformation and Business Expansion

The approved resolutions encompass comprehensive changes including the company's strategic pivot from Genesis IBRC India Limited to CCME Global Limited. Shareholders endorsed business expansion into FMCG, commodities, and minerals sectors with an estimated investment of up to INR 3,000.00 lakhs targeting Middle East markets.

Board Leadership Appointments

The postal ballot approved significant board restructuring to support the company's new strategic direction. Ms. Poonam Chaturvedi was appointed as Managing Director and has been instrumental in securing the BSE approval, as evidenced by her signature on the regulatory submission dated March 12, 2026.

Next Steps and Regulatory Compliance

With BSE's in-principle approval secured, the company must now complete ROC formalities before submitting the final name change application to the exchange. BSE has reserved the right to withdraw approval if any information is found incomplete or incorrect. The company maintains full regulatory compliance documentation on its website at www.genesisil.com and CDSL's e-voting platform for stakeholder transparency.